HomeMy WebLinkAboutR-2025-142 Resolution approving the Washington State Allocation Agreement Governing the Allocation of Funds Paid by the Purdue Bankruptcy, Sacklers, and Certain Opioid Manufacturers and participation in the Purdue, Alvogen, Amneal, Apotex, Hikma, IndivioRESOLUTION NO. R-2025-142
A RESOLUTION approving the Washington State Allocation Agreement Governing the
Allocation of Funds Paid by the Purdue Bankruptcy, Sacklers, and Certain
Opioid Manufacturers and participation in the Purdue, Alvogen, Amneal,
Apotex, Hikma, Indivior, Mylan, Sun, and Zydus Settlements.
WHEREAS, the City approved the One Washington Memorandum of Understanding
Between Washington Municipalities and its Allocation Agreement III, which the City agreed to
settle any claims it might have against certain pharmaceutical supply chain entities,
manufacturers and distributors in exchange for a percentage of the total negotiated settlement
amounts; and
WHEREAS, a tentative settlement has now been reached with nine manufacturers:
Purdue, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan Sun, and Zydus, in the total amount of
$122.2 million to be paid over the next fifteen (15) years; and
WHEREAS, the City is entitled to take advantage of these settlement amounts due to its
participation in the One Washington memorandum; and
WHEREAS, to take advantage of the settlement funding the City must approve said
settlement agreements by agreeing to the Washington State Allocation Agreement Governing the
Allocation of Funds Paid by the Purdue Bankruptcy, Sacklers, and Certain Opioid Manufacturers
("Allocation Agreement IV") and filling out and returning the Participation Forms for each
settlement by the deadline; and
WHEREAS, the City Council finds that it is in the best interest of the City of Yakima and
its residents to enter into the settlement agreements with Purdue, Alvogen, Amneal, Apotex,
Hikma, Indivior, Mylan Sun, and Zydus; and to secure a portion of the settlement proceeds to be
used in the City of Yakima for approved uses as outlined in the One Washington Memorandum
and Allocation Agreement IV; now, therefore,
BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF YAKIMA:
The City Council of the City of Yakima hereby authorizes the City Manager to sign the
Washington State Allocation Agreement Governing the Allocation of Funds Paid by the Purdue
Bankruptcy, Sacklers, and Certain Opioid Manufacturers ("Allocation Agreement IV"), the
Participation Forms for the Purdue, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan Sun, and
Zydus Settlement Agreements, and all necessary documents and contracts to effectuate the
settlements.
ADOPTED BY THE CITY COUNCIL this 16ih day Q
AIIEST:
osalinda Ibarra, City Clerk
Item No. 7.H.
For Meeting of: September 16, 2025
ITEM TITLE:Resolution approving the Washington State Allocation Agreement
Governing the Allocation of Funds Paid by the Purdue Bankruptcy,
Sacklers, and Certain Opioid Manufacturers and participation in the
Purdue, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and
Zydus Settlements
SUBMITTED BY:Sara Watkins, City Attorney
BUSINESS OF THE CITY COUNCIL
YAKIMA, WASHINGTON
AGENDA STATEMENT
SUMMARY EXPLANATION:
The Washington State Attorney General has reached settlement with nine opioid manufacturers,
including Purdue, regarding their role in the opioid epidemic. The settlement totaled $122.2 million to the
State of Washington and the individual jurisdictions, payable over fifteen years.
As with the other settlements, the City of Yakima is allocated 0.6060410539% (after costs and attorneys’
fees are taken from the settlement proceeds). The estimated state total, assuming full participation from
all jurisdictions, from the settlements is $105,598,053.62. Based on the above percentage, the
estimated amount Yakima may receive is $639,967.55. This is scheduled to be paid out in various
amounts over the course of 16 payments.
To take advantage of the settlements, and receive settlement funds, the City must join the settlements by
executing a number of documents and agreeing to the proposed updated Allocation Agreement. As with
the previous distributor, manufacturer and other settlements, this settlement is contingent on eligible
cities and counties joining the settlements, and the City will receive a percentage share of the settlement
proceeds allocated to local jurisdictions.
Information about the settlement can be found here: https://www.atg.wa.gov/purdue-pharma-and-
generic-manufacturers-settlements
ITEM BUDGETED: No
STRATEGIC PRIORITY 24-25: A Safe and Healthy Yakima
RECOMMENDATION: Adopt Resolution.
ATTACHMENTS:
Resolution_allocation agmt re opioid settlements_Purdue Bankruptcy
UpdatedSettlementPacket_20250728_
Updated_Local_Government_Payments-2025-07-10
National Opioid Settlement Notice_Settlement Overview.pdf